| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Proteasome degradation", "2": "Metapathway biotransformation phase i and ii", "3": "Mitochondrial complex iv assembly", "4": "Nonalcoholic fatty liver disease", "5": "Myometrial relaxation and contraction pathways", "6": "Calcium regulation in cardiac cells", "7": "Type i collagen synthesis in the context of osteogenesis imperfecta", "8": "Ccl18 signaling pathway", "9": "Ethanol effects on histone modifications", "10": "Alzheimers disease", "11": "Oxidative phosphorylation", "12": "Sphingolipid metabolism overview", "13": "Sphingolipid metabolism integrated pathway", "14": "Alzheimers disease and mirna effects", "15": "Tryptophan metabolism", "16": "Mitochondrial complex i assembly model oxphos system", "17": "Ferroptosis", "18": "Omega9 fatty acid synthesis", "19": "Insulin signaling", "20": "Head and neck squamous cell carcinoma", "21": "Il18 signaling pathway", "22": "Fatty acid transporters", "23": "Ppar signaling pathway", "24": "Fragile x syndrome", "25": "Glycogen synthesis and degradation", "26": "Envelope proteins and their potential roles in edmd physiopathology", "27": "Leukocyteintrinsic hippo pathway functions"} |